Deportation practices in the USA continue to undermine the communication and disability rights of asylum seekers with disabilities, especially deaf individuals, causing serious health consequences and ...

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders through chronic inflammation. However, its role in multiple sclerosis, a ...

Among multiple sclerosis (MS) patients, those with a high relative abundance of Fusobacterium nucleatum together with other periodontal bacteria were more likely to have moderate to severe disability ...

Lipoic acid (LA), an oral antioxidant supplement, was not associated with greater improvements in timed walking speed or other clinical outcomes in patients with progressive multiple sclerosis (MS) ...

The step training program did not improve ankle proprioception or plantarflexor muscle performance in MS patients. No significant differences were observed between intervention and control groups in ...

Disability progression in relapsing MS follows four patterns: minimal, late, early, or rapid worsening. Progression independent of relapse activity (PIRA) was the main driver of disability worsening ...

Findings showed treatment with tolebrutinib did not significantly delay disability progression compared with placebo. A phase 3 study evaluating tolebrutinib for the treatment of primary progressive ...

Multiple sclerosis (MS) is a chronic neurodegenerative disease that frequently causes neurogenic lower urinary tract dysfunction (NLUTD). More than 75% of patients experience urinary symptoms that ...

Objective: To investigate the current status and determinants of fatigue and to examine the relationship between fatigue and quality of life (QOL) in patients with neuromyelitis optica (NMO). Methods: ...

Cladribine was associated with similar relapse rates and MRI activity as sphingosine-1-phosphate receptor modulators (S1PRMs) in treatment-naive patients with relapsing-remitting multiple sclerosis ...